123 related articles for article (PubMed ID: 15862962)
1. Regulation of aromatase activity by cytokines, PGE2 and 2-methoxyoestrone-3-O-sulphamate in fibroblasts derived from normal and malignant breast tissues.
Purohit A; Ghilchik MW; Leese MP; Potter BV; Reed MJ
J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):167-72. PubMed ID: 15862962
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of tumor necrosis factor alpha-stimulated aromatase activity by microtubule-stabilizing agents, paclitaxel and 2-methoxyestradiol.
Purohit A; Singh A; Ghilchik MW; Reed MJ
Biochem Biophys Res Commun; 1999 Jul; 261(1):214-7. PubMed ID: 10405348
[TBL] [Abstract][Full Text] [Related]
3. Regulation of aromatase and sulphatase in breast tumour cells.
Purohit A; Wang DY; Ghilchik MW; Reed MJ
J Endocrinol; 1996 Sep; 150 Suppl():S65-71. PubMed ID: 8943789
[TBL] [Abstract][Full Text] [Related]
4. Control of aromatase activity in breast tumours: the role of the immune system.
Singh A; Purohit A; Duncan LJ; Mokbel K; Ghilchik MW; Reed MJ
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):185-92. PubMed ID: 9365189
[TBL] [Abstract][Full Text] [Related]
5. Regulation of aromatase activity within the breast.
Miller WR; Mullen P; Sourdaine P; Watson C; Dixon JM; Telford J
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):193-202. PubMed ID: 9365190
[TBL] [Abstract][Full Text] [Related]
6. The regulation and inhibition of 17beta-hydroxysteroid dehydrogenase in breast cancer.
Purohit A; Tutill HJ; Day JM; Chander SK; Lawrence HR; Allan GM; Fischer DS; Vicker N; Newman SP; Potter BV; Reed MJ
Mol Cell Endocrinol; 2006 Mar; 248(1-2):199-203. PubMed ID: 16414180
[TBL] [Abstract][Full Text] [Related]
7. The regulation of aromatase activity in breast fibroblasts: the role of interleukin-6 and prostaglandin E2.
Singh A; Purohit A; Ghilchik MW; Reed MJ
Endocr Relat Cancer; 1999 Jun; 6(2):139-47. PubMed ID: 10731102
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-2 directly regulates gene expression of P450 Cyp19 aromatase promoter regions pII, pI.3 and pI.7 and estradiol production in human breast tumor cells.
Prosperi JR; Robertson FM
Prostaglandins Other Lipid Mediat; 2006 Oct; 81(1-2):55-70. PubMed ID: 16997132
[TBL] [Abstract][Full Text] [Related]
9. Determinants of tissue oestradiol levels in human breast cancer.
Santen RJ
Cancer Surv; 1986; 5(3):597-616. PubMed ID: 3555785
[TBL] [Abstract][Full Text] [Related]
10. Regulation of breast cancer-associated aromatase promoters.
Chen D; Reierstad S; Lu M; Lin Z; Ishikawa H; Bulun SE
Cancer Lett; 2009 Jan; 273(1):15-27. PubMed ID: 18614276
[TBL] [Abstract][Full Text] [Related]
11. Paracrine-stimulated gene expression profile favors estradiol production in breast tumors.
Amin SA; Huang CC; Reierstad S; Lin Z; Arbieva Z; Wiley E; Saborian H; Haynes B; Cotterill H; Dowsett M; Bulun SE
Mol Cell Endocrinol; 2006 Jul; 253(1-2):44-55. PubMed ID: 16735089
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of IL-6+IL-6 soluble receptor-stimulated aromatase activity by the IL-6 antagonist, Sant 7, in breast tissue-derived fibroblasts.
Purohit A; Singh A; Ghilchik MW; Serlupi-Crescenzi O; Reed MJ
Br J Cancer; 2003 Feb; 88(4):630-5. PubMed ID: 12592380
[TBL] [Abstract][Full Text] [Related]
13. Aromatase and the breast: regulation and clinical aspects.
Miller WR
Maturitas; 2006 Jul; 54(4):335-41. PubMed ID: 16730141
[TBL] [Abstract][Full Text] [Related]
14. (Anti)estrogenic effects of phytochemicals on human primary mammary fibroblasts, MCF-7 cells and their co-culture.
van Meeuwen JA; Korthagen N; de Jong PC; Piersma AH; van den Berg M
Toxicol Appl Pharmacol; 2007 Jun; 221(3):372-83. PubMed ID: 17482226
[TBL] [Abstract][Full Text] [Related]
15. The effect of 2-methoxyoestrone-3-O-sulphamate on the growth of breast cancer cells and induced mammary tumours.
Purohit A; Hejaz HA; Walden L; MacCarthy-Morrogh L; Packham G; Potter BV; Reed MJ
Int J Cancer; 2000 Feb; 85(4):584-9. PubMed ID: 10699934
[TBL] [Abstract][Full Text] [Related]
16. Oestrogen formation in breast: clinical and biological importance.
Dowsett M; Detre S; Rowlands M; Grimshaw R
J Endocrinol; 1996 Sep; 150 Suppl():S59-63. PubMed ID: 8943788
[TBL] [Abstract][Full Text] [Related]
17. Aromatase inhibition by synthetic lactones and flavonoids in human placental microsomes and breast fibroblasts--a comparative study.
van Meeuwen JA; Nijmeijer S; Mutarapat T; Ruchirawat S; de Jong PC; Piersma AH; van den Berg M
Toxicol Appl Pharmacol; 2008 May; 228(3):269-76. PubMed ID: 18201740
[TBL] [Abstract][Full Text] [Related]
18. Aromatase inhibitors and breast cancer.
Miller WR
Minerva Endocrinol; 2006 Mar; 31(1):27-46. PubMed ID: 16498362
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of aromatase activity in breast fibroblasts by tumor necrosis factor alpha.
Macdiarmid F; Wang D; Duncan LJ; Purohit A; Ghilchick MW; Reed MJ
Mol Cell Endocrinol; 1994 Dec; 106(1-2):17-21. PubMed ID: 7895904
[TBL] [Abstract][Full Text] [Related]
20. Oestrone sulphatase activity in normal and malignant breast tissues: relationship with tumour location.
Chapman O; Purohit A; Wang DY; Ghilchik MW; Reed MJ
Anticancer Res; 1995; 15(4):1467-71. PubMed ID: 7654035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
